A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
NCT05810038
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
787
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Rimegepant
DRUG:
Placebo
Sponsor
Pfizer